Biotech News Butler
Atrogi doses first subjects for ATR-258
2 articles curated from biotech news
Atrogi begins dosing first subjects in human trial of ATR-258
PharmaTimes
Mar 18, 2026
Atrogi announces first subjects dosed in human trial for lead candidate ATR-258
PR Newswire - Health
Mar 18, 2026
Share:
Post
Share
Want daily biotech news like this?
Sign up free